AB Science Stock Plummets 31% In Turbulent Trading Day
(VIANEWS) – Shares of AB SCIENCE Plunge 31.66% in Value Loss About AB SCIENCE AB Science S.A. is a pharmaceutical company focused on researching, developing and marketing protein kinase inhibitors for human and veterinary medicines. Their lead compound masitinib, a tyrosine kinase inhibitor currently in Phase III trials for multiple indications such as prostate and…